Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
West Pharmaceutical Services, Inc. (WST) had Free Cash Flow per Share of $0.65 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$844.90M |
|
$138.80M |
|
$548.50M |
|
$296.40M |
|
$667.80M |
|
$177.10M |
|
$3.00M |
|
$180.10M |
|
$180.10M |
|
$135.40M |
|
$138.80M |
|
$138.80M |
|
$135.40M |
|
$177.10M |
|
$222.30M |
|
72.00M |
|
72.40M |
|
$1.93 |
|
$1.92 |
|
| Balance Sheet Financials | |
$1.83B |
|
$1.70B |
|
$2.28B |
|
$4.11B |
|
$674.00M |
|
$202.80M |
|
$445.40M |
|
$1.12B |
|
$2.99B |
|
$2.87B |
|
$2.99B |
|
70.90M |
|
| Cash Flow Statement Financials | |
$89.90M |
|
$-42.70M |
|
$-308.70M |
|
$791.30M |
|
$521.40M |
|
$-269.90M |
|
$6.60M |
|
$-15.80M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.71 |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
35.08% |
|
20.96% |
|
20.96% |
|
-- |
|
21.32% |
|
16.43% |
|
$47.20M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
1.21 |
|
1.23 |
|
73.03 |
|
4.64% |
|
4.83% |
|
3.38% |
|
4.35% |
|
$42.18 |
|
|
Free Cash Flow per Share |
$0.65 |
$1.24 |
|